Obsessive-Compulsive Disorder

Imagem de Miniatura
Arquivos
art_CASTALDELLI-MAIA_ObsessiveCompulsive_Disorder_2015.PDF (489.69 KB)
Citações na Scopus
0
Tipo de produção
bookPart
Data de publicação
2015
DOI
Scopus
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER INC.
Autores
Citação
Castaldelli-Maia, J. M.. Obsessive-Compulsive Disorder. In: . INTERNATIONAL ENCYCLOPEDIA OF THE SOCIAL & BEHAVIORAL SCIENCES: SECOND EDITION: ELSEVIER INC., 2015. p.113-118.
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Obsessive-Compulsive Disorder (OCD) is a chronic, disabling disorder that is characterized by the presence of obsessions and/or compulsions. OCD groups with other related disorders such as body dysmorphic disorder, hoarding disorder, trichotillomania (hair-pulling disorder), excoriation (skin-picking) disorder, and other disorders. However, it is important to note that this group of disorders guard close proximity with anxiety disorders. The prognosis of OCD improved dramatically with the introduction of special cognitive-behavioral techniques and the use of selective serotonin reuptake inhibitors. At present, researchers attempt to integrate psychological, behavioral, neurochemical, and neuroanatomical findings in a comprehensive psychobiological model of OCD. © 2015 Elsevier Ltd. All rights reserved.
Palavras-chave
Body dysmorphic disorder, CBT, Cognitive-behavioral therapy, Compulsions, Excoriation disorder, Hoarding disorder, Obsessions, Obsessive-compulsive disorder (OCD), Persistent thoughts, Repetitive behaviors, Selective serotonin reuptake inhibitors, Skin-picking disorder, SSRI, Trichotillomania (hair-pulling disorder)
URI
https://observatorio.fm.usp.br/handle/OPI/51177
Referências
  1. (2013) Diagnostic and Statistical Manual of Mental Disorders, , American Psychiatric Association, Arlington, VA
  2. Benkelfat, C., Murphy, D.L., Zohar, J., Hill, J.L., Grover, G., Insel, T.R., Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action (1989) Archives of General Psychiatry, 46, pp. 23-28
  3. Bihari, K., Hill, J.L., Murphy, D.L., Obsessive-compulsive characteristics in patients with idiopathic spasmodic torticollis (1992) Psychiatry Research, 42, pp. 267-272
  4. Bloch, M.H., Landeros-Weisenberger, A., Kelmendi, B., Coric, V., Bracken, M.B., Leckman, J.F., A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder (2006) Molecular Psychiatry, 11 (7), pp. 622-632
  5. Broocks, A., Pigott, T.A., Hill, J.L., Canter, S., Grady, T.A., L'Heureux, F., Murphy, D.L., Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive-compulsive disorder (OCD): behavioral and biological results (1998) Psychiatry Research, 79, pp. 11-20
  6. Broocks, A., Thiel, A., Angerstein, D., Dressler, D., Higher prevalence of obsessive-compulsive symptoms in patients with blepharospasm than in patients with hemifacial spasm (1998) American Journal of Psychiatry, 155, pp. 555-557
  7. Charney, D.S., Goodman, W.K., Price, L.H., Woods, S.W., Rasmussen, S.A., Heninger, G.R., Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects (1988) Archives of General Psychiatry, 45, pp. 177-185
  8. De Araujo, L.A., Ito, L.M., Marks, I.M., Early compliance and other factors predicting outcome of exposure for obsessive-compulsive disorder (1996) British Journal of Psychiatry, 169, pp. 747-752
  9. Dold, M., Aigner, M., Lanzenberger, R., Kasper, S., Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials (2013) International Journal of Neuropsychopharmacology, 16 (3), pp. 557-574
  10. Foa, E.B., Liebowitz, M.R., Kozak, M.J., Davies, S., Campeas, R., Franklin, M.E., Huppert, J.D., Tu, X., Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder (2005) American Journal of Psychiatry, 162 (1), pp. 151-161
  11. Hand, I., Out-patient, multi-modal behaviour therapy for obsessive-compulsive disorder (1998) British Journal of Psychiatry, pp. 45-52. , (Suppl.)
  12. Hoehn, S.R., Ninan, P., Black, D.W., Stahl, S., Greist, J.H., Lydiard, B., McElroy, S., Harrison, W., Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders (2000) Archives of General Psychiatry, 57, pp. 76-82
  13. Hohagen, F., Winkelmann, G., Rasche, R.H., Hand, I., Konig, A., Munchau, N., Hiss, H., Berger, M., Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo. Results of a multicentre study (1998) British Journal of Psychiatry, pp. 71-78. , (Suppl.)
  14. Hollander, E., DeCaria, C.M., Nitescu, A., Gully, R., Suckow, R.F., Cooper, T.B., Gorman, J.M., Liebowitz, M.R., Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers (1992) Archives of General Psychiatry, 49, pp. 21-28
  15. Kostic, V.S., Stojanovic-Svetel, M., Kacar, A., Symptomatic dystonias associated with structural brain lesions (1996) Canadian Journal of Neurological Sciences, 23, pp. 53-56
  16. Kozak, M.J., Liebowitz, M.R., Foa, E.B., Cognitive behavior therapy and pharmacotherapy for OCD (1999) Obsessive-Compulsive Disorder: Contemporary Issues in Treatment, , Harper, Washington, DC, W.K. Goodman (Ed.)
  17. Laplane, D., Levasseur, M., Pillon, B., Dubois, B., Baulac, M., Mazoyer, B., Tran Dinh, S., Baron, J.C., Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions. A neuropsychological, magnetic resonance imaging and positron tomography study (1989) Brain, 112, pp. 699-725
  18. Lopes, A.C., de Mathis, M.E., Canteras, M.M., Salvajoli, J.V., Del Porto, J.A., Miguel, E.C., Update on neurosurgical treatment for obsessive compulsive disorder (2004) Revista Brasileira de Psiquiatria, 26 (1), pp. 62-66
  19. Lopes, A.C., Greenberg, B.D., Norén, G., Canteras, M.M., Busatto, G.F., de Mathis, M.E., Taub, A., Miguel, E.C., Treatment of resistant obsessive-compulsive disorder with ventral capsular/ventral striatal gamma capsulotomy: a pilot prospective study (2009) Journal of Neuropsychiatry and Clinical Neurosciences, 21 (4), pp. 381-392
  20. Murphy, D.L., Greenberg, B., Altemus, M., Benjamin, J., Grady, T., Pigott, T., The neuropharmacology and neurobiology of obsessive-compulsive disorder (1996) Advances in the Neurobiology of Anxiety Disorders, pp. 279-297. , John Wiley & Sons Ltd, H.G.M. Westenberg (Ed.)
  21. Pato, M.T., Zohar-Kadouch, R., Zohar, J., Murphy, D.L., Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder (1991) American Journal of Psychiatry, 145, pp. 1521-1525
  22. Pauls, D.L., Leckman, J.F., Towbin, K.E., Zahner, G.E., Cohen, D.J., A possible genetic relationship exists between Tourette's syndrome and obsessive-compulsive disorder (1986) Psychopharmacology Bulletin, 22, pp. 730-733
  23. Pauls, D.L., The genetics of obsessive-compulsive disorder: a review (2010) Dialogues in Clinical Neurosciences, 12, pp. 149-163
  24. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial (2004) Journal of the American Medical Association, 292, pp. 1969-1976. , Pediatric OCD Treatment Study (POTS) Team
  25. Pigott, T.A., Pato, M.T., Bernstein, S.E., Grover, G.N., Hill, J.L., Tolliver, T.J., Murphy, D.L., Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results (1990) Archives of General Psychiatry, 47, pp. 926-932
  26. Pigott, T.A., Seay, S.M., A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder (1999) Journal of Clinical Psychiatry, 60, pp. 101-106
  27. Purcell, R., Maruff, P., Kyrios, M., Pantelis, C., Neuropsychological deficits in obsessive-compulsive disorder: a comparison with unipolar depression, panic disorder, and normal controls (1998) Archives of General Psychiatry, 55, pp. 415-423
  28. Rauch, S.L., Neuroimaging and Neurocircuitry models pertaining to the neurosurgical treatment of psychiatric disorders (2003) Neurosurgery Clinics of North America, 14, pp. 6-9
  29. Salkovskis, P.M., Understanding and treating obsessive-compulsive disorder (1999) Behavioral Research and Therapy, pp. S29-52
  30. Schilder, P., The organic background of obsessions and compulsions (1938) American Journal of Psychiatry, 94, pp. 1397-1414
  31. Schmidtke, K., Schorb, A., Winkelmann, G., Hohagen, F., Cognitive frontal lobe dysfunction in obsessive-compulsive disorder (1998) Biological Psychiatry, 43, pp. 666-673
  32. Schwartz, J.M., (1996) Brain Lock, , Harper Collins, New York
  33. Schwartz, J.M., Neuroanatomical aspects of cognitive-behavioural therapy response in obsessive-compulsive disorder. An evolving perspective on brain and behaviour (1998) British Journal of Psychiatry, pp. 38-44
  34. Shavitt, R.G., Diniz, J.B., Torres, A.R., Alvarenga, P.G., Cordás, T.A., Transtornos do espectro compulsivo ao longo da vida (2012) Compêndio de clínica psiquiátrica, , Manole, Barueri, SP, Brazil, O.V. Forlenza, E.C. Miguel (Eds.)
  35. Skoog, G., Skoog, I., A 40-year follow-up of patients with obsessive-compulsive disorder (1999) Archives of General Psychiatry, 56, pp. 121-127
  36. Swedo, S.E., Rapoport, J.L., Cheslow, D.L., Leonard, H.L., Ayoub, E.M., Hosier, D.M., Wald, E.R., High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea (1989) American Journal of Psychiatry, 146, pp. 246-249
  37. Teixeira, A.L., Rodrigues, D.H., Marques, A.H., Miguel, E.C., Fontenelle, L.F., Searching for the immune basis of obsessive-compulsive disorder (2014) Neuroimmunomodulation, 21 (2-3), pp. 152-158
  38. Williams, M.T., Farris, S.G., Turkheimer, E.N., Franklin, M.E., Simpson, H.B., Liebowitz, M., Foa, E.B., The impact of symptom dimensions on outcome for exposure and ritual prevention therapy in obsessive-compulsive disorder (2014) Journal of Anxiety Disorders, 28 (6), pp. 553-558
  39. Zohar, J., Insel, T.R., Zohar Kadouch, R.C., Hill, J.L., Murphy, D.L., Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment (1988) Archives of General Psychiatry, 45, pp. 167-172
  40. Zücher, S., Wendland, J.R., Ashley-Koch, A.E., Collins, A.L., Tran-Viet, K.N., Quinn, K., Timpano, K.C., Murphy, D.L., Multiple rare SAPAP3 missense variants in trichotillomania and OCD (2010) Molecular Psychiatry, 14, pp. 6-9

Coleções
Livros e Capítulos de Livros - FM/Outros
Livros e Capítulos de Livros - LIM/23